Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Mechanisms of the Anti-Tumor Activity of STAT3 Degraders in Lymphoma

Blood (2020) 136 (Supplement 1): 42.

https://doi.org/10.1182/blood-2020-137778

Published: 2020

Journal Articles

Small Molecule-Induced, Selective STAT3 Degradation Leads to Anti-Tumor Activity in STAT3-Dependent Heme Malignancies

Fred Csibi, Nan Ji, PhD, Bin Yang, Karen Yuan, Michele Mayo, Haojing Rong, PhD, Scott Rusin, Kirti Sharma, Christine Loh, PhD, Henry Li, PhD, Sharon Townson, Jesse Chen, PhD, Hari Kamadurai, PhD, Duncan Walker, PhD, Jared Gollob, PhD MD, Nello Mainolfi, PhD

Blood (2019) 134 (Supplement_1): 3803.

https://doi.org/10.1182/blood-2019-128981

Published: 2019

Journal Articles

Alteration of CD47 Expression in Human and Murine Tumor Models Changes M1/M2 Phagocytosis Effect in Vitro and In Vivo

Huajun Yang, Zhongliang Li, Beibei Tang, Zegen Wang, Phillip Wang, Henry Li, PhD, Mohamad A. Cherry, MDMS, Frank Xing

Blood (2018) 132 (Supplement 1): 2395.

https://doi.org/10.1182/blood-2018-99-120268

Published: 2018

Journal Articles

Heterogeneous Responses Among Ph + -B-ALLs to Imatinib with NRAS Mutant Being One Mechanism of Complete Resistance

Xiaoyu An, Jinping Liu, Na Wang, MD PhD, Di Wang, MD PhD, Liang Huang, MD PhD, Jie Cai, PhD, Demin Zhou, PhD, Henry Li, PhD

Blood (2018) 132 (Supplement 1): 5801.

https://doi.org/10.1182/blood-2018-99-115516

Published: 2018

Journal Articles

Experimental Modeling of Acute- and Chronic-GvHD By Xenotransplanting Human Donor PBMCs or Cord Blood CD34 + Cells (HSC) into NSG Mice

Ann E Lin, PhD, Sonia Reyes, Xiaoyu An, Sonia Reyes, Wenqing Yang, PhD, Derron Yu, Duan Dan, PhD, Henry Li, PhD

Blood (2018) 132 (Supplement 1): 5684.

https://doi.org/10.1182/blood-2018-99-115462

Published: 2018

Journal Articles

Targeted Degradation of IRAK4 Protein Via Heterobifunctional Small Molecules for Treatment of MYD88 Mutant Lymphoma

Joseph Kelleher, PhD, Laurent Audoly, PhD, Veronica Campbell, Jesse Chen, PhD, Nan Ji, PhD, Hari Kamadurai, PhD, Henry Li, PhD, Christine Loh, PhD, Haojing Rong, PhD, Dominico Vigil, PhD, Matt Weiss, PhD, Karen Yuan, Yi Zhang, PhD, Nello Mainolfi, PhD

Blood (2018) 132 (Supplement 1): 2953.

https://doi.org/10.1182/blood-2018-99-120148

Published: 2018

NARROW

Mechanisms of the Anti-Tumor Activity of STAT3 Degraders in Lymphoma

Small Molecule-Induced, Selective STAT3 Degradation Leads to Anti-Tumor Activity in STAT3-Dependent Heme Malignancies

Alteration of CD47 Expression in Human and Murine Tumor Models Changes M1/M2 Phagocytosis Effect in Vitro and In Vivo

Heterogeneous Responses Among Ph + -B-ALLs to Imatinib with NRAS Mutant Being One Mechanism of Complete Resistance

Experimental Modeling of Acute- and Chronic-GvHD By Xenotransplanting Human Donor PBMCs or Cord Blood CD34 + Cells (HSC) into NSG Mice

Targeted Degradation of IRAK4 Protein Via Heterobifunctional Small Molecules for Treatment of MYD88 Mutant Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Mechanisms of the Anti-Tumor Activity of STAT3 Degraders in Lymphoma

Small Molecule-Induced, Selective STAT3 Degradation Leads to Anti-Tumor Activity in STAT3-Dependent Heme Malignancies

Alteration of CD47 Expression in Human and Murine Tumor Models Changes M1/M2 Phagocytosis Effect in Vitro and In Vivo

Heterogeneous Responses Among Ph + -B-ALLs to Imatinib with NRAS Mutant Being One Mechanism of Complete Resistance

Experimental Modeling of Acute- and Chronic-GvHD By Xenotransplanting Human Donor PBMCs or Cord Blood CD34 + Cells (HSC) into NSG Mice

Targeted Degradation of IRAK4 Protein Via Heterobifunctional Small Molecules for Treatment of MYD88 Mutant Lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only